Pre-Open Stock Movers 09/21: (GNMK) (ZKIN) (NXPI) Higher; (LLY) (DKNG) (MGNI) Lower (more...)
Get Alerts VRCA Hot Sheet
Join SI Premium – FREE
Pre-Open Stock Movers:
Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24.8% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.
ReWalk Robotics Ltd. (Nasdaq: RWLK) 17% HIGHER; sees pre-open upside.
Uber (NYSE: UBER) 6.2% HIGHER; presented its updated Q3 outlook today to say it now expects Q3 bookings between $22.8 billion and $23.2 billion (from $22 billion to $24 billion reported in Q2).
Aprea Therapeutics, Inc. (Nasdaq: APRE) 4.9% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.
Steven Madden (NASDAQ: SHOO) 4.7% HIGHER; Jefferies upgraded from Hold to Buy with a price target of $50.00 (from $44.00).
Cano Health (NYSE: CANO) 3.3% HIGHER; Citi initiates coverage with a Buy rating and a price target of $20.00.
KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.
SmileDirectClub, Inc. (Nasdaq: SDC) 2.5% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.
Lennar Corp. (NYSE: LEN) 2.3% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citius Pharmaceuticals (CTXR) Announces FDA Acceptance of BLA Resubmission of LYMPHIR for Treatment of Adults with R/R Cutaneous T-Cell Lymphoma
- Citi Upgrades Regions Financial (RF) to Buy, 'Lessons Learned'
- Legend Biotech (LEGN) Announces CARVYKTI Receives Recommendation from FDA Committee for Earlier Treatment of Patients with R/R Multiple Myeloma
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Stifel, Citi, Jefferies & Co, Pre-Open Losers, Pre-Open Winners, Pre Market Movers, PDUFA, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!